Related Experiment Video
Updated: May 5, 2026
06:23
Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
8.0K
Hemostasis, coagulation abnormalities, and liver disease
Carole L Mackavey1, Robert Hanks
1University of Texas Health Science Center at Houston, Houston, TX, USA.
Critical Care Nursing Clinics of North America
|November 26, 2013
Summary
Managing bleeding in liver disease is complex due to coagulopathy. This review discusses subtle patient changes and interventions for critical complications, aiding providers in patient care.
Area of Science:
- Hepatology
- Hematology
- Critical Care Medicine
Background:
- Coagulopathy-related bleeding is a significant complication in acute and chronic liver disease.
- The liver's role in balancing procoagulant and anticoagulant factors is crucial.
- Providers face challenges with poor prognostic indicators for managing bleeding events.
Purpose of the Study:
- To discuss the complexities of managing coagulopathy-related bleeding in liver disease.
- To highlight subtle patient presentation changes requiring intervention.
- To review essential provider-directed interventions for critical complications.
Main Methods:
- Literature review and synthesis of current clinical practices.
- Discussion of diagnostic challenges and prognostic indicators.
- Analysis of management strategies for bleeding complications.
Main Results:
- Subtle changes in patient presentation often precede severe bleeding events.
- Effective management requires a multi-faceted approach including fluid management and sepsis evaluation.
- Pharmacologic treatments play a role in mitigating bleeding risks.
Conclusions:
- Improved understanding of subtle clinical signs is vital for early intervention.
- Comprehensive management strategies are necessary to address bleeding in liver disease patients.
- Further research into prognostic indicators can enhance patient outcomes.
Related Concept Videos
01:24Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
386
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
386
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
01:22Portal Hypertension
57
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
57
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K